Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A high-density screen for linkage in multiple sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Saccadic intrusions: review and update.
Safety issue puts daclizumab in doubt for MS
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Molecular properties of epithelial, amiloride-blockable Na+ channels.
Roche's MabThera approved for two vasculitis indications in UK
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
Phase II Cladribine Add-on to Interferon-beta (IFN-b) Therapy in MS Subjecs With Active Disease (ONWARD)
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Overcoming barriers in progressive multiple sclerosis research.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
Physiopathological Roles of p2x Receptors in the Central Nervous System.
A complex role of herpes viruses in the disease process of multiple sclerosis.
Disease-modifying treatments for progressive multiple sclerosis.
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.

Pages